TRPV1 and periodontitis: In both in vivo and in vitro inflammatory modeling environments, the expression of TRPV1 was identically increased, suggesting that TRPV1 might positively affect periodontal inflammation and become a new therapeutic target for inflammatory diseases such as periodontitis.